Identification of Prognostic Biomarkers Originating From the Tumor Stroma of Betel Quid-Associated Oral Cancer Tissues

• Published in: Frontiers in oncology 2021-11, Vol.11, p.769665-769665
• Main Authors: Liu, Yi-Hong, Chen, Yu-Lian, Lai, Ting-Yu, Ko, Ying-Chieh, Chou, Yu-Fu, Chen, Peir-Rong, Hsiao, Jenn-Ren, Chang, Jang-Yang, Shiah, Shine-Gwo, Lee, Jeng-Woei, Yang, Jia-Ling, Lin, Su-Fang
• Format: Article
• Language: English
• Subjects: inflammatory CAF (iCAF); myofibroblastic CAF (myCAF); Oncology; oral cancer; partial epithelial-mesenchymal transition (p-EMT); prognostic biomarkers; tumor stroma
• ISSN: 2234-943X; 2234-943X
• DOI: 10.3389/fonc.2021.769665

Partial epithelial-mesenchymal transition (p-EMT) is a distinct clinicopathological feature prevalent in oral cavity tumors of The Cancer Genome Atlas. Located at the invasion front, p-EMT cells require additional support from the tumor stroma for collective cell migration, including track clearing, extracellular matrix remodeling and immune evasion. The pathological roles of otherwise nonmalignant cancer-associated fibroblasts (CAFs) in cancer progression are emerging. Gene set enrichment analysis was used to reveal differentially enriched genes and molecular pathways in OC3 and TW2.6 xenograft tissues, representing mesenchymal and p-EMT tumors, respectively. R packages of genomic data science were executed for statistical evaluations and data visualization. Immunohistochemistry and Alcian blue staining were conducted to validate the bioinformatic results. Univariate and multivariate Cox proportional hazards models were performed to identify covariates significantly associated with overall survival in clinical datasets. Kaplan-Meier curves of estimated overall survival were compared for statistical difference using the log-rank test. Compared to mesenchymal OC3 cells, tumor stroma derived from p-EMT TW2.6 cells was significantly enriched in microvessel density, tumor-excluded macrophages, inflammatory CAFs, and extracellular hyaluronan deposition. By translating these results to clinical transcriptomic datasets of oral cancer specimens, including the Puram single-cell RNA-seq cohort comprising ~6000 cells, we identified the expression of stromal and as independent poor and protective biomarkers, respectively, for 40 Taiwanese oral cancer tissues that were all derived from betel quid users. In The Cancer Genome Atlas, was a poor marker not only for head and neck cancer but also for additional six cancer types and was a good indicator for four tumor cohorts, suggesting common stromal effects existing in different cancer types. As the tumor stroma coevolves with cancer progression, the cellular origins of molecular markers identified from conventional whole tissue mRNA-based analyses should be cautiously interpreted. By incorporating disease-matched xenograft tissue and single-cell RNA-seq results, we suggested that and , primarily expressed by stromal CAFs and endothelial cells, respectively, could serve as robust prognostic biomarkers for oral cancer control.